RATIONAL DRUG DESIGN OF POTENT V600E-BRAF KINASE INHIBITORS THROUGH MOLECULAR DOCKING SIMULATION
B-RAF is a one of the RAF protein kinase group that contribute to the development of different types of cancer. V600E-BRAF protein has lot potential for scientific investigation as the therapeutic target owing to its participation in melanoma cancer and is the molecular target of many anticancer co...
Saved in:
Main Authors: | Bello Abdullahi Umar, Adamu Uzairu, Gideion Adamu Shallangwa, Sani Uba |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade Federal de Viçosa (UFV)
2019-12-01
|
Series: | The Journal of Engineering and Exact Sciences |
Subjects: | |
Online Access: | https://periodicos.ufv.br/jcec/article/view/8460 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frecuencia de la inmunosupresión de BRAF V600E en ameloblastomas: Un análisis multi-insituticional de 86 casos en América Latina
by: Lauren Frenzel Schuch, et al.
Published: (2024-12-01) -
BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience
by: S. S. McThenia, et al.
Published: (2025-01-01) -
Melanoma genomics – will we go beyond BRAF in clinics?
by: Justyna Mirek, et al.
Published: (2024-09-01) -
BRAF V600E-mutated lung adenocarcinoma with thyroid metastasis as the initial manifestation: a case report
by: Yufei Liu, et al.
Published: (2025-02-01) -
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
by: Arianna Marinello, MD, et al.
Published: (2025-03-01)